NCT06229236Completed
Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies
Assessing Effectiveness of a Diabetes Navigator in Increasing Progression (Improving Uptake and/or Optimization) of Advanced Diabetes Technologies
Source: ClinicalTrials.gov · Last updated 23 Sept 2026
Brief summary (registry, in English)
The goal of this randomized control trial is to determine if the support of a Diabetes Navigator is more effective than standard care in improving uptake and use of advanced diabetes technology among patients with type 1 diabetes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 148 (actual)
- First submitted
- 19 Jan 2024
- Start date
- 13 Feb 2024
- Primary completion date
- 26 Aug 2025
- Lead sponsor
- Johns Hopkins University
- Diseases
- Type 1 diabetes
- NCT number
- NCT06229236
What you commit to
- Study type: Interventional
- Participants enrolled: 148
- From 13 Feb 2024 to the primary completion date, 26 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Optimally using Diabetes Technology
- Other types of diabetes (type 2 diabetes, Maturity Onset Diabetes in Youth, cystic fibrosis-related diabetes, steroid-induced diabetes, post total pancreatectomy, transplant-related diabetes)
- Active participant of any other research study that may interfere with diabetes management.
Other
- Pregnancy or lactation or planned pregnancy in the next 12 months.
Who the study is looking for
- Male or female aged 5 to 75 years.
- Diagnosis of type 1 diabetes
- Patient of Johns Hopkins Medicine adult or pediatric diabetes clinics
- Not using or not optimally using diabetes technology.
- Planned Diabetes technology intensification by diabetes provider.
- If already on diabetes technology - must be using the specific device for a minimum of 14 days.
Age in the registry: 5 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins University School Of Medicine Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.